Barbara Eichhorst
MD
Professor of Internal Medicine; Deputy Director, CLL Study Group
👥Biography 个人简介
Barbara Eichhorst leads the German CLL Study Group (GCLLSG) and has been instrumental in developing and validating MRD-guided fixed-duration treatment strategies for CLL. She led the CLL14 trial of venetoclax plus obinutuzumab and has contributed to establishing undetectable MRD as a surrogate endpoint and treatment-stopping criterion. Her research evaluates optimal MRD monitoring methods and the prognostic value of deep molecular remissions. She contributes to European and global CLL treatment guideline development.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Barbara Eichhorst 的研究动态
Follow Barbara Eichhorst's research updates
留下邮箱，当我们发布与 Barbara Eichhorst（University Hospital of Cologne）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment